Capillary Technologies India Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/m3a76nxme4o9bbe1w4iei1bq.pdf

Key Takeaways


The Organic + Inorganic Growth Model

Reddy: "the entire ledger for all the earn and burn, how many points you've earned, how many points you've redeemed, how many have expired, how many promotion points, bonus points... that entire ledger like a bank ends up sitting on our side"

Profitability: The Reported PAT Dip vs. The Underlying Trajectory


aiRA: The AI Layer That Changes the Competitive Game

Reddy: "Our biggest competitors are agencies... a large part of aiRA for us is really saying if you needed 30 people in an agency to run loyalty program you will need five on Capillary... it's just a massive differentiator, no agency will do it because it hits them harder than for us anyway we don't monetize that right?"

Vertical & Customer Dynamics


Product & Platform Evolution

Reddy: "I think all enterprise software is not equal. So I would break enterprise software into really three big buckets... system of record... system of engagement... system of intelligence... what's happening with AI is really I think the second bucket, which is the system of engagement and the system of intelligence are definitely seeing the most amount of... spaces, which is where we are kind of focusing our aiRA stuff on"

Guidance & Commitments

CommitmentSpecificsTimeline
Healthcare revenue contributionRevenue from the large US healthcare payer to be seen through CY26 following the 50% member base increase from January 1 go-livesThrough CY26
aiRA monetizationConvert POC-stage customers to paid annual licenses linked to usage; first three months free pilot, then chargeFirst conversions now in discussion
M&A pipeline closureA couple of letters of intent in the marketNo timeline given
Technology cost leverageFurther improvement on below-COGS items as a percentage of revenueOngoing
Cost growth trajectoryInflation plus a few more points for team growthOngoing

Key Metrics

MetricQ3 FY26
Revenue₹184 cr, +16% YoY
9M FY26 revenue₹543 cr, +22% YoY
Adjusted EBITDA₹30 cr, +24% YoY
Adjusted EBITDA margin16.4%, vs 15.3% in Q3 FY25
PAT₹8 cr, 4.3% of revenue, vs ₹11.4 cr in Q3 FY25; flat YoY after normalizing for one-time costs
One-time costs in PAT₹3.6 cr total: ₹1.6 cr gratuity (Direct Labour Code change) and ₹2 cr IPO expenses
Depreciation and amortization₹19 cr, vs ₹13 cr in Q3 FY25, increase largely from Kognitiv acquisition
Closing cash balance₹463 cr
9M operating cash flow₹101 cr, vs 9M adjusted EBITDA of ₹71 cr
Net revenue retention (TTM, Dec 2025)111%; organic NRR 115%, inorganic NRR 96%
ARR growth (9M FY26 over Mar 2025)21%
New customers added12 in 9M FY26, 3 in Q3
New order book (9M FY26)₹66 cr, vs ₹53 cr in same period last year
Gross margin69–70% for Capillary platform; 1.5% increase in gross margins through first 9 months
aiRA adoption10–15 customers in POC or post-POC stage, out of 115 total